7-Deazaadenine → 3-(1-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)ethyl)-4-phenyl-1H-isochromen-1-one
Reaction equation
Br[CH:2]([C:4]1[O:5][C:6](=[O:20])[C:7]2[C:12]([C:13]=1[C:14]1[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=1)=[CH:11][CH:10]=[CH:9][CH:8]=2)[CH3:3].[N:21]1[C:26]2[NH:27][CH:28]=[CH:29][C:25]=2[C:24]([NH2:30])=[N:23][CH:22]=1>>[NH2:30][C:24]1[C:25]2[CH:29]=[CH:28][N:27]([CH:2]([C:4]3[O:5][C:6](=[O:20])[C:7]4[C:12]([C:13]=3[C:14]3[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=3)=[CH:11][CH:10]=[CH:9][CH:8]=4)[CH3:3])[C:26]=2[N:21]=[CH:22][N:23]=1Participants
3
Procedure
The title compound was made in a similar way as that of the compound of example 1 using 3-(1-bromoethyl)-4-phenyl-1H-isochromen-1-one (intermediate C7, 50 mg, 0.15 mmol), 7H-pyrrolo[2,3-d]pyrimidin-4-amine (30.6 mg, 0.23 mmol) to give the title compound (16 mg, 28%).
Sources & evidence
- ORD record
- ord-c3038c22a481451f8ce8bef2ba4f7784
- Source dataset
- uspto-grants-2016_04
- Patent number
- US09321776B2
Reaction notes
Loading…